Inflammation

Items 11-20 of 31

per page
Set Descending Direction
  1. Epoxomicin
    CAS  134381-21-8
    AG-CN2-0422
    AG-CN2-0422-C05050 µg
    CHF 90.00
    AG-CN2-0422-C100100 µg
    CHF 150.00
    AG-CN2-0422-C250250 µg
    CHF 290.00
    AG-CN2-0422-C500500 µg
    CHF 450.00
    Epoxomicin
  2. KTSAVLQ-Rhodamine110-γ-Glu
    SBB-PS0130
    SBB-PS0130-C250250 µg
    CHF 616.00
    KTSAVLQ-Rhodamine110-γ-Glu
  3. MLN4924 [NAE Inhibitor]
    CAS  905579-51-3
    AG-CR1-3703
    AG-CR1-3703-M0055 mg
    CHF 120.00
    AG-CR1-3703-M02525 mg
    CHF 480.00
    MLN4924 [NAE Inhibitor]
  4. MLN4924 [NAE Inhibitor] Solution
    CAS  905579-51-3
    AG-CS1-0103
    AG-CS1-0103-M0011 mg
    CHF 250.00
    MLN4924 [NAE Inhibitor] Solution
  5. Mpro [3CLpro] (SARS-CoV-2) (rec.) (His)
    SBB-DE0129
    SBB-DE0129-C05050 µg
    CHF 322.00
  6. Parthenolide
    CAS  20554-84-1
    AG-CN2-0455
    AG-CN2-0455-M01010 mg
    CHF 35.00
    AG-CN2-0455-M05050 mg
    CHF 80.00
    AG-CN2-0455-M250250 mg
    CHF 240.00
    Parthenolide
  7. PLpro (SARS Coronavirus) (rec.) (His)
    SBB-DE0024
    SBB-DE0024-C05050 µg
    CHF 278.00
  8. PLpro (SARS-CoV-2) (rec.) (His)
    SBB-DE0127
    SBB-DE0127-C05050 µg
    CHF 322.00
  9. SUMO1 (human) (rec.) (Rhodamine 110)
    SBB-PS0028
    SBB-PS0028-C05050 µg
    CHF 434.00
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO1-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.
  10. SUMO2 (human) (rec.) (Rhodamine 110)
    SBB-PS0029
    SBB-PS0029-C05050 µg
    CHF 434.00
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO2-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.

Items 11-20 of 31

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.